Strengthening health systems around the world


+ Show all
  • Commissioning Party

    German Federal Ministry for Economic Cooperation and Development (BMZ)

  • Cofinancier

    European Union (EU), British Foreign, Commonwealth and Development Office (FCDO), Swiss Agency for Development and Cooperation (SDC)

  • Country


  • Lead executing agency


  • Overall term

    2020 to 2026

  • Products and expertise

    Social development

Women are sitting in a circle listening to an adjunct professor holding a notebook. © CiCDoc


Infectious diseases such as human immunodeficiency virus (HIV), tuberculosis and malaria still cause several million deaths each year and are responsible for a high burden of disease in the world’s poorest countries. Almost 100 million people fall into poverty each year due to illness: this is the result of insufficiently developed and underfinanced health systems. The COVID-19 pandemic has also highlighted the importance of a functioning health system.

Developing and expanding resilient health systems is one of the keys to achieving UN Sustainable Development Goal 3. To this end, greater use is to be made of funding from global and intergovernmental initiatives – such as the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) and the Providing for Health (P4H) network – to strengthen health systems.

Two women visiting a doctor at her practice and taking notes. © GIZ / BACKUP Health


Cooperation partners make efficient use of resources provided by global and intergovernmental initiatives to strengthen health systems.


The project advises GFATM recipient countries on aligning the financing with national priorities and using the resources to strengthen their health systems.

It also facilitates better coordination among donors in the P4H network and encourages the implementation of national reforms to ensure long-term, equitable health financing.

In addition, it seeks to enhance the conditions for expanding local vaccine production in Africa. This supports the African Union’s target of increasing the share of vaccines produced on the continent from 1 per cent to 60 per cent by 2040.

Promoting gender equality and civil-society involvement is a particular priority for the project.

A man wearing a lab coat examines two samples in test tubes. © GIZ/Nadia Said

Last update: April 2023

Additional information